TARA CIK: 1359931

Protara Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
93.1
FY22:
86.1
FY23:
68.7
FY24:
172
FY25:
160
(positive)
Change from FY21 to FY25
millions USD
FY21:
79.5
FY22:
27.1
FY23:
10.2
FY24:
9.30
FY25:
50.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
173
FY22:
113
FY23:
79.0
FY24:
181
FY25:
209

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.30
FY22:
5.74
FY23:
6.15
FY24:
11.0
FY25:
10.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.38
FY22:
5.47
FY23:
4.48
FY24:
3.36
FY25:
2.12
(positive)
Change from FY21 to FY25
millions USD
FY21:
162
FY22:
102
FY23:
68.3
FY24:
167
FY25:
196
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
173
FY22:
113
FY23:
79.0
FY24:
181
FY25:
209

All amounts in millions USD Data source:SEC EDGAR